
Pharma Pulse 6/17/24: Medicinal Plants in Modern Pharmacy, Dynamic Pricing & more
The latest news for pharma industry insiders.
In this Pharmaceutical Commerce video interview, Blake Powers, CEO of Medigi, discusses his first byline with the publication, along with why the industry may be stuck in its ways in certain aspects.
Researchers are working to solve consistency and ecological and ethical concerns in pharmaceutical formulations.
Sites can encounter a wide range of challenges when operationalizing study protocols, including the need to manage frequent and lengthy patients visits, coordinate complicated procedure schedules and utilize multiple disparate technology systems. Applied analytics enable data-driven protocol design that can help sponsors mitigate these trial challenges.
Data collected from sites can help uncover specific protocol elements that drive sites’ perception of burden. These findings can be used to optimize protocol design to decrease burden and improve site experience, potentially leading to positive outcomes such as facilitating the collection of cleaner data and improving protocol compliance.
Companies are jumping into the red-hot GLP-1 market with a surprising new target: pets. But first...
Collaboration aims to accelerate speed to diagnosis and treatment of hypertrophic cardiomyopathy.
Marketing gurus...check out the latest Pharmaceutical Executive eBook featuring insights from LiveWorld's very own Danny Flamberg. Him and I had a great discussion about embracing change with digital capabilities.
https://lnkd.in/eA3rFnu5
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor 
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

